national compounding company, inc.

111 eighth ave 13th floor
new york, new york 10011

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 14, 2013

NYS DOS ID#
4360632

County
ERIE

Jurisdiction
FLORIDA

Registered Agent
NATIONAL REGISTERED AGENTS, INC.
111 EIGHTH AVE 13TH FLOOR
NEW YORK, NEW YORK, 10011

NYS Entity Type
FOREIGN BUSINESS CORPORATION

Name History
2013 - NATIONAL COMPOUNDING COMPANY, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Eli Lilly Fronts $55M for Rights to KeyBioscience’s Diabetes Drugs
    By Frank Vinluan - Thursday Jun 8, 2017

    With competition threatening to chip away at its diabetes stronghold, Eli Lilly is shoring up its pipeline with a deal that gives the company access to a potential new class of diabetes drugs. Indianapolis-based Lilly (NYSE: LLY) has agreed to pay $55 million up front to KeyBioscience in exchange for rights to compounds in various […]

    Source: Xconomy VC, Deals, & Startups Feed
  • North Korea Accuses U.S. of ‘Mugging’ Its Diplomats in New York
    By CHOE SANG-HUN - Sunday Jun 18, 2017

    Officials returning from a United Nations conference were about to board a plane when federal agents seized a package they were carrying.

    Source: NYT > Home Page
  • Time Inc. Cuts 300 Jobs
    Wednesday Jun 14, 2017

    Time Inc., the nation's largest magazine publisher, announced a new round of layoffs and buyouts, affecting 300 positions or around 4% of the company's total headcount. Its shrinking headcount hasbeen a bellwether for the travails of legacy print publishers as ad dollars shifted to digital media over the last decade.

    Source: Media Post: MediaDailyNews
  • Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
    By Ben Fidler - Tuesday Jun 13, 2017

    A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]

    Source: Xconomy New York